↓ Skip to main content
What is this page? Embed badge

Treatment of Asthma: The long-acting beta-2-agonists

Overview of attention for book
Cover of 'Treatment of Asthma: The long-acting beta-2-agonists'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Molecular regulation of the β 2 -adrenergic receptor by long- and short-acting β-agonists
  3. Altmetric Badge
    Chapter 2 Molecular interactions between glucocorticoids and β 2 -agonists
  4. Altmetric Badge
    Chapter 3 Formoterol, a new long-acting β 2 -agonist
  5. Altmetric Badge
    Chapter 4 Development of the long-acting β 2 -agonist, salmeterol
  6. Altmetric Badge
    Chapter 5 Development of bambuterol; a long acting, orally active beta-agonist prodrug
  7. Altmetric Badge
    Chapter 6 Development of β2-receptors in infancy and childhood
  8. Altmetric Badge
    Chapter 7 Long-acting beta-agonists in exercise induced asthma
  9. Altmetric Badge
    Chapter 8 Salmeterol and oral steroid treatment
  10. Altmetric Badge
    Chapter 9 Salmeterol and its relationship to treatment with inhaled corticosteroids
  11. Altmetric Badge
    Chapter 10 Long term treatment with formoterol
  12. Altmetric Badge
    Chapter 11 Comparison of efficiency of bambuterol and salmeterol
  13. Altmetric Badge
    Chapter 12 The future of relievers and controllers in asthma therapy
Attention for Chapter 10: Long term treatment with formoterol
Altmetric Badge

Citations

dimensions_citation
1 Dimensions
Summary Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Long term treatment with formoterol
Chapter number 10
Book title
Treatment of Asthma: The long-acting beta-2-agonists
Published by
Springer, Vienna, January 1998
DOI 10.1007/978-3-7091-7513-2_10
Book ISBNs
978-3-21-183124-3, 978-3-70-917513-2
Authors

Michael Rudolf

View on publisher site

This page is provided by Altmetric.